Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $7.64 million. The enterprise value is $1.73 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 21.83 million shares outstanding. The number of shares has increased by 176.70% in one year.
| Current Share Class | 21.83M |
| Shares Outstanding | 21.83M |
| Shares Change (YoY) | +176.70% |
| Shares Change (QoQ) | +62.43% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 2.60% |
| Float | 21.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.02
| Current Ratio | 5.02 |
| Quick Ratio | 4.88 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -171.27% and return on invested capital (ROIC) is -105.17%.
| Return on Equity (ROE) | -171.27% |
| Return on Assets (ROA) | -88.32% |
| Return on Invested Capital (ROIC) | -105.17% |
| Return on Capital Employed (ROCE) | -148.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.69M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -176.70% |
| Shareholder Yield | -176.70% |
| Earnings Yield | -110.54% |
| FCF Yield | -84.80% |
Analyst Forecast
The average price target for ADIL is $4.75, which is 1,256.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.75 |
| Price Target Difference | 1,256.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -18.82% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |